Form 8-K - Current report:
SEC Accession No. 0001193125-25-160501
Filing Date
2025-07-17
Accepted
2025-07-17 16:01:26
Documents
13
Period of Report
2025-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d75954d8k.htm   iXBRL 8-K 30311
2 EX-10.1 d75954dex101.htm EX-10.1 1123775
  Complete submission text file 0001193125-25-160501.txt   1527727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dva-20250717.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dva-20250717_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dva-20250717_pre.xml EX-101.PRE 10810
15 EXTRACTED XBRL INSTANCE DOCUMENT d75954d8k_htm.xml XML 3468
Mailing Address 2000 16TH STREET DENVER CO 80202
Business Address 2000 16TH STREET DENVER CO 80202 310-536-2668
DAVITA INC. (Filer) CIK: 0000927066 (see all company filings)

EIN.: 510354549 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14106 | Film No.: 251130635
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)